Novo Nordisk A/S - share repurchase programme
06 Februar 2024 - 8:20AM
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 6 February 2024 – The
execution of Novo Nordisk A/S’ overall share repurchase programme
for 2024 of DKK 20 billion will be initiated on 6 February 2024. As
part of this, Novo Nordisk A/S has now initiated a new share
repurchase programme of up to DKK 2.1 billion in accordance with
Article 5 of Regulation No 596/2014 of the European Parliament and
Council of 16 April 2014 (MAR) and the Commission Delegated
Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour
Rules”).
The purpose of the programme is to reduce the company’s share
capital and to meet obligations arising from share-based incentive
programmes. B shares of DKK 0.10 will be repurchased during the
trading period starting 6 February 2024 and ending on 30 April
2024. A maximum of 350,000,000 B shares of DKK 0.10 in total can be
bought during the trading period.
Novo Nordisk is a leading global healthcare company, founded in
1923 and headquartered in Denmark. Our purpose is to drive change
to defeat serious chronic diseases, built upon our heritage in
diabetes. We do so by pioneering scientific breakthroughs,
expanding access to our medicines, and working to prevent and
ultimately cure disease. Novo Nordisk employs about 63,400 people
in 80 countries and markets its products in around 170 countries.
Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B).
Its ADRs are listed on the New York Stock Exchange (NVO). For more
information, visit novonordisk.com, Facebook, Instagram, X,
LinkedIn and YouTube.
Contacts for further information
Media: |
|
Ambre
James-Brown +45 3079 9289abmo@novonordisk.com |
Elizabeth
DeLuca (US)+1 609 580 9868edel@novonordisk.com |
Investors: |
|
Daniel
Muusmann Bohsen+45 3075 2175 dabo@novonordisk.com |
Jacob
Martin Wiborg Rode+45 3075 5956jrde@novonordisk.com |
David
Heiberg Landsted +45 3077 6915 dhel@novonordisk.com |
Mark
Joseph Root (US) +1 848 213 3219mjhr@novonordisk.com |
Sina
Meyer +45 3079 6656azey@novonordisk.com |
Frederik
Taylor Pitter +45 3075 8259fptr@novonordisk.com |
Company announcement No 10 / 2024
- CA240206-share-repurchase-initiation
Novo Nordisk (TG:NOV)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Novo Nordisk (TG:NOV)
Historical Stock Chart
Von Mai 2023 bis Mai 2024